a public good project by the
Synthesis
Company
of California

© 2026

Alexander Muckenhuber | doi.page

0 works0 citations0 h-index

Alexander Muckenhuber

German Cancer Research Center(DE)DKFZ-ZMBH Alliance(DE)Technical University of Munich(DE)

Publications by Year

Research Areas

Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, AI in cancer detection, Cancer Immunotherapy and Biomarkers

Most-Cited Works

→ CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma(2016)226 cited
→ Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin(2020)126 cited
→ Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach(2013)112 cited
→ Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response(2017)101 cited
→ SUMO pathway inhibition targets an aggressive pancreatic cancer subtype(2020)99 cited
→ Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells(2019)77 cited

→ A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy(2019)

74 cited

→ pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma(2017)63 cited

→ Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix(2018)61 cited

→ Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast—implications for tumor biology and pathological diagnosis(2015)58 cited